EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

A new method of screening for inherited disorders of galactose metabolism



A new method of screening for inherited disorders of galactose metabolism



Journal of Laboratory and Clinical Medicine 99(6): 895-907



A method has been developed for detecting elevated levels of galactose and galactose-1-phosphate in routine blood samples of newborns and has been successfully applied as a screening procedure for galactosemia in several laboratories. The procedure utilizes a strain of Escherichia coli that becomes resistant to bacteriophage C21 in the presence of galactose. The presence of galactose or galactose-1-phosphate is detected as a zone of bacterial growth around blood spots placed on a dish in which the bacteria are otherwise killed by phage. The diameter of the growth zone is proportional to the concentration of total blood galactose. The procedure has the potential of detecting all metabolic abnormalities that can lead to the accumulation of galactose or galactose-1-phosphate. Over a million newborn infants have now been tested by this procedure in three countries. In the New England Regional Screening Program, 12 galactosemic children were detected in 825,403 live births. One additional case, a sibling of a previously diagnosed galactosemic, was not allowed any milk feeding and was detected by an enzymatic test of cord blood. The combined frequency was 1:63,000. No problems of interference by antibiotics were apparent. Use of the test in Switzerland and in Japan also allowed the discovery of infants with UDP galactose 4-epimerase deficiency. Our experience suggests that the test provides an efficient and reliable means of detecting congenital defects of galactose metabolism with a very low frequency of errors. It can also be used to monitor blood galactose levels in the management of galactosemic children.

(PDF 0-2 workdays service: $29.90)

Accession: 001038837

Download citation: RISBibTeXText

PMID: 7042875



Related references

An improved screening method for inherited disorders of purine and pyrimidine metabolism by HPLC. Advances in Experimental Medicine and Biology 309b: 7-10, 1991

Diagnosis of inherited disorders of galactose metabolism. Current Protocols in Human Genetics Chapter 17: Unit 17.5-Unit 17.5, 2008

Screening method for inherited disorders of purine and pyrimidine metabolism by capillary electrophoresis with reversed electroosmotic flow. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 767(2): 333-340, 2002

Neonatal screening for inherited metabolic disorders Evaluation of GC/MS method. Journal of Inherited Metabolic Disease 23(Supplement 1): 9, July, 2000

European quality assurance program for the selective screening of inherited disorders of metabolism. Journal of Inherited Metabolic Disease 19(SUPPL 1): 104, 1996

The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annual Review of Genomics and Human Genetics 3: 17-45, 2002

A fluorogenic allele-specific amplification method for DNA-based screening for inherited metabolic disorders. Acta Paediatrica Supplement (432): 65-68, 1999

A fluorogenic allele-specific amplification method for DNA-based screening for inherited metabolic disorders. Acta Paediatrica . Supplement 88(432): 65-68, 2000

Mutation screening of the calcium-sensing receptor gene by denaturing HPLC in the diagnosis of inherited disorders of parathyroid hormone metabolism. American Journal of Human Genetics 73(5): 402, November, 2003

Galactose metabolites and disorders of galactose metabolism. Hommes, F A (Ed ) Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual Xiii+646p Wiley-Liss: New York, New York, Usa; Chichester, England, Uk Illus 267-284, 1991

Urine uric acid to creatinine ratio - a screening test for inherited disorders of purine metabolism. Phosphoribosyltransferase (PRT) deficiency in X-linked cerebral palsy and in a variant of gout. J. Pediat, 73: 583-592, 1968

Studies on galactose metabolism in heart and brain: the identification of D-galactose 6-phosphate in brains of galactose-intoxicated chicks and rat hearts perfused with galactose. Archives of Biochemistry and Biophysics 165(1): 217-228, 1974

Urine uric acid to creatinine ratio a screening test for inherited disorders of purine metabolism enz phospho ribosyl transferase deficiency in x linked cerebral palsy and in a variant of gout human. Journal of Pediatrics 73(4): 583-592, 1968

Ultrasound screening in pregnancy and neonatal mass screening for inherited metabolic disorders in austria. Wiener Klinische Wochenschrift 101(16): 527-529, 1989